Spots Global Cancer Trial Database for Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
Official Title: An Open Phase III Trial With Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
Study ID: NCT00332852
Conditions
Interventions
Study Description
Brief Summary: This is a prospective open-label one-arm phase III trial designed to evaluate the safety and efficacy of letrozole 2.5 mg administered orally daily for 24 months as adjuvant therapy in postmenopausal patients with primary breast cancer. This trial is not recruiting patients in the United States.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Novartis Investigative Site, Albstadt, , Germany
Schorndorf, Augsburg, , Germany
Novartis Investigative Site, Bamberg, , Germany
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Bonn, , Germany
Novartis Investigative Site, Bottrop, , Germany
Novartis Investigative Site, Braunschweig, , Germany
Novartis Investigative site, Celle, , Germany
Novartis Investigative Site, Chemnitz, , Germany
Novartis Investigative Site, Dortmund, , Germany
Novartis Investigative Site, Frankfurt, , Germany
Novartis Investigative Site, Fulda, , Germany
Novartis Investigative Site, Gera, , Germany
Novartis Investigative Site, Gütersloh, , Germany
Novartis Investigative Site, Hamburg, , Germany
Novartis Investigative Site, Hameln, , Germany
Novartis Investigative Site, Hannover, , Germany
Novartis Investigative Site, Herne, , Germany
Novartis Investigative Site, Holzminden, , Germany
Novartis Investigative Site, Hoxter, , Germany
Novartis Investigative Site, Ilsede, , Germany
Novartis Investigative Site, Itzehoe, , Germany
Novartis Investigative Site, Jena, , Germany
Novartis Investigative Site, Karlsruhe, , Germany
Novartis Investigative Site, Kempten, , Germany
Novartis Investigative Site, Konigs, , Germany
Schorndorf, Konstanz, , Germany
Novartis Investigative Site, Lich, , Germany
Novartis Investigative Site, Lohsa/Weisskollm, , Germany
Novartis Investigative Site, Ludwigsburg, , Germany
Novartis Investigative Site, Memmingen, , Germany
Novartis Investigative Site, Muhlhausen, , Germany
Novartis Investigative Site, Munchen, , Germany
Novartis Investigative Site, Munster, , Germany
Novartis Investigative Site, Neumunster, , Germany
Novartis Investigative Site, Neunkirchen, , Germany
Novartis Investigative Site, Offenburg, , Germany
Novartis Investigative Site, Pforzheim, , Germany
Novartis Investigative Site, Rendsburg, , Germany
Novartis Investigative Site, Saarbrucken, , Germany
Novartis Investigative Site, Saarbrücken, , Germany
Novartis Investigative Site, Saarlouis, , Germany
Novartis Investigative Site, Salzgitter, , Germany
Novartis Investigative Site, Schorndorf, , Germany
Novartis Investigative Site, Schwetzingen, , Germany
Novartis Investigative Site, St. Wendel, , Germany
Novartis Investigative Site, Starnberg, , Germany
Novartis Investigative Site, Stuttgart, , Germany
Novartis Investigative Site, Tuttlingen, , Germany
Novartis Investigative Site, Ulm, , Germany
Novartis Investigative Site, Walsrode, , Germany
Novartis Investigative Site, Westerburg, , Germany
Novartis Investigative Site, Wiesbaden, , Germany
Novartis Investigative Site, Wolfsburg, , Germany
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmeceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
